Search Results

411 articles with title/keywords/abstract containing Controlled-release-drugs

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
modify search
Display per page 

Content loaded within last 14 days Venlafaxine: Tinnitus: case report

Source: Reactions, Volume 1, Number 1279, 2009-11-21 , pp. 34-34(1)

Publisher: Adis International

Octreotide: Severe and prolonged hypoglycaemia: case report

Source: Reactions, Volume 1, Number 1259, 2009-07-04 , pp. 23-23(1)

Publisher: Adis International

Niacin: Coagulopathy: case report

Source: Reactions, Volume 1, Number 1262, 2009-07-25 , pp. 23-23(1)

Publisher: Adis International

Venlafaxine: Hyperprolactinaemia: case report

Source: Reactions, Volume 1, Number 1257, 2009-06-20 , pp. 44-44(1)

Publisher: Adis International

Verapamil overdose: Colonic ischaemia: case report

Source: Reactions, Volume 1, Number 1257, 2009-06-20 , pp. 44-44(1)

Publisher: Adis International

Hydroxypropylcellulose opthalmic insert improves QOL in DES

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 579, 2009-05-30 , pp. 12-12(1)

Publisher: Adis International

Risperidone: Periorbital oedema: case report

Source: Reactions, Volume 1, Number 1231, 2008-12-06 , pp. 26-26(1)

Publisher: Adis International

Actavis gains approval for generic bupropion ER 150mg tablets.

Source: Inpharma, Volume 1, Number 1667, 2008-12-06 , pp. 21-21(1)

Publisher: Adis International

Tapentadol immediate-release tablets approved in US.

Source: Inpharma, Volume 1, Number 1667, 2008-12-06 , pp. 22-22(1)

Publisher: Adis International

Generic version of Wellbutrin XL [bupropion] approved by US FDA

Source: Inpharma, Volume 1, Number 1667, 2008-12-06 , pp. 22-22(1)

Publisher: Adis International

A sustained-release (SR) preparation of fampridine improves walking ability in a subgroup of patients with multiple sclerosis

Source: Inpharma, Volume 1, Number 1664, 2008-11-15 , pp. 8-8(1)

Publisher: Adis International

CV Therapeutics has announced that the US FDA has approved a new, first-line indication for ranolazine extended-release tablets

Source: Inpharma, Volume 1, Number 1664, 2008-11-15 , pp. 22-22(1)

Publisher: Adis International

Quetiapine formulations approved in Europe.

Source: Inpharma, Volume 1, Number 1665, 2008-11-22 , pp. 22-22(1)

Publisher: Adis International

US FDA tentatively approves generic version of antidepressant Effexor.

Source: Inpharma, Volume 1, Number 1665, 2008-11-22 , pp. 23-23(1)

Publisher: Adis International

Treprostinil may not offer freedom from PAH

Source: Inpharma, Volume 1, Number 1666, 2008-11-29 , pp. 18-18(1)

Publisher: Adis International

Abbott receives complete response letter from US FDA for hydrocodone with paracetamol [acetaminophen].

Source: Inpharma, Volume 1, Number 1661, 2008-10-25 , pp. 17-17(1)

Publisher: Adis International

AstraZeneca seeking approval for quetiapine in Europe.

Source: Inpharma, Volume 1, Number 1661, 2008-10-25 , pp. 18-18(1)

Publisher: Adis International

Paliperidone puts in performance for schizoaffective disorder

Source: Inpharma, Volume 1, Number 1663, 2008-11-08 , pp. 16-16(1)

Publisher: Adis International

Fesoterodine receives US FDA approval

Source: Inpharma, Volume 1, Number 1663, 2008-11-08 , pp. 22-22(1)

Publisher: Adis International

Mesalazine granted US FDA approval for ulcerative colitis.

Source: Inpharma, Volume 1, Number 1663, 2008-11-08 , pp. 23-23(1)

Publisher: Adis International

modify search
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A